Detection of autoantibodies against heat shock proteins and collapsin response mediator proteins in autoimmune retinopathy

Grazyna Adamus, Robert Bonnah, Lori Brown, Larry David

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background: Autoimmune retinopathy (AR) and Cancer-Associated Retinopathy (CAR) are associated with a diverse repertoire of anti-retinal autoantibodies (AAbs) but not all antigenic targets have been characterized. Identification of new AAbs may help with clinical diagnosis and prognosis of retinal dysfunction in AR. The goal was to identify frequently targeted retinal autoantigens within the 60-70-kDa molecular weight range. Methods. Human retinal proteins were separated by SDS-PAGE and 2D gel electrophoresis (2-DE) and sera from AR patients with and without cancer were used to identify immunoreactive proteins by Western blotting. Proteins were identified following separation by electrophoresis, Coomassie staining using in-gel trypsin digestion and mass spectrometric analysis. Circulating serum hsp60 and anti-hsp60 antibody levels were determined by quantitative ELISA. Results: Retrospective evaluation of 819 patients with anti-retinal AAbs showed that 29% patients had AAbs targeted proteins between 60-70-kDa. Shotgun mass spectrometry of human retinal proteins present in 1D-gel found 66 species within this range. To identify the immunoreactive proteins, we performed Western blots of 2-DE gels and showed a group of heat shock proteins (hsps), including hsp60 and CRMP proteins that were frequently recognized by AR patient AAbs, irrespective of cancer status. These results were validated by immunostaining of purified hsp60 and CRMP2 proteins. ELISA results revealed that patients with AR and CAR had significantly increased levels of serum anti-hsp60 antibodies compared to control healthy subjects (p <0.0001). However, circulating hsp60 protein was not significantly elevated in sera of either patient group. Conclusions: Different anti-retinal antibodies frequently co-exist in a single patient, creating antibody-arrays related to the syndrome. Hsps and CRMP-2 are newly identified autoantigens in AR. A frequent co-association of anti-hsp antibodies with other anti-retinal AAbs may augment pathogenic processes, leading to retinal degeneration.

Original languageEnglish (US)
Article number48
JournalBMC Ophthalmology
Volume13
Issue number1
DOIs
StatePublished - 2013

Fingerprint

Semaphorin-3A
Heat-Shock Proteins
Autoantibodies
Chaperonin 60
Ocular Paraneoplastic Syndromes
Proteins
Anti-Idiotypic Antibodies
Gels
Electrophoresis, Gel, Two-Dimensional
Autoantigens
Serum
Western Blotting
Enzyme-Linked Immunosorbent Assay
Retinal Degeneration
Antibodies
Firearms
Trypsin
Electrophoresis
Polyacrylamide Gel Electrophoresis
Digestion

Keywords

  • Autoantibody
  • Autoantigen
  • Autoimmune retinopathy
  • CAR
  • CRMP-2
  • Heat shock proteins
  • Retina

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Detection of autoantibodies against heat shock proteins and collapsin response mediator proteins in autoimmune retinopathy. / Adamus, Grazyna; Bonnah, Robert; Brown, Lori; David, Larry.

In: BMC Ophthalmology, Vol. 13, No. 1, 48, 2013.

Research output: Contribution to journalArticle

@article{f58b1c278a774916b350a08059230754,
title = "Detection of autoantibodies against heat shock proteins and collapsin response mediator proteins in autoimmune retinopathy",
abstract = "Background: Autoimmune retinopathy (AR) and Cancer-Associated Retinopathy (CAR) are associated with a diverse repertoire of anti-retinal autoantibodies (AAbs) but not all antigenic targets have been characterized. Identification of new AAbs may help with clinical diagnosis and prognosis of retinal dysfunction in AR. The goal was to identify frequently targeted retinal autoantigens within the 60-70-kDa molecular weight range. Methods. Human retinal proteins were separated by SDS-PAGE and 2D gel electrophoresis (2-DE) and sera from AR patients with and without cancer were used to identify immunoreactive proteins by Western blotting. Proteins were identified following separation by electrophoresis, Coomassie staining using in-gel trypsin digestion and mass spectrometric analysis. Circulating serum hsp60 and anti-hsp60 antibody levels were determined by quantitative ELISA. Results: Retrospective evaluation of 819 patients with anti-retinal AAbs showed that 29{\%} patients had AAbs targeted proteins between 60-70-kDa. Shotgun mass spectrometry of human retinal proteins present in 1D-gel found 66 species within this range. To identify the immunoreactive proteins, we performed Western blots of 2-DE gels and showed a group of heat shock proteins (hsps), including hsp60 and CRMP proteins that were frequently recognized by AR patient AAbs, irrespective of cancer status. These results were validated by immunostaining of purified hsp60 and CRMP2 proteins. ELISA results revealed that patients with AR and CAR had significantly increased levels of serum anti-hsp60 antibodies compared to control healthy subjects (p <0.0001). However, circulating hsp60 protein was not significantly elevated in sera of either patient group. Conclusions: Different anti-retinal antibodies frequently co-exist in a single patient, creating antibody-arrays related to the syndrome. Hsps and CRMP-2 are newly identified autoantigens in AR. A frequent co-association of anti-hsp antibodies with other anti-retinal AAbs may augment pathogenic processes, leading to retinal degeneration.",
keywords = "Autoantibody, Autoantigen, Autoimmune retinopathy, CAR, CRMP-2, Heat shock proteins, Retina",
author = "Grazyna Adamus and Robert Bonnah and Lori Brown and Larry David",
year = "2013",
doi = "10.1186/1471-2415-13-48",
language = "English (US)",
volume = "13",
journal = "BMC Ophthalmology",
issn = "1471-2415",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Detection of autoantibodies against heat shock proteins and collapsin response mediator proteins in autoimmune retinopathy

AU - Adamus, Grazyna

AU - Bonnah, Robert

AU - Brown, Lori

AU - David, Larry

PY - 2013

Y1 - 2013

N2 - Background: Autoimmune retinopathy (AR) and Cancer-Associated Retinopathy (CAR) are associated with a diverse repertoire of anti-retinal autoantibodies (AAbs) but not all antigenic targets have been characterized. Identification of new AAbs may help with clinical diagnosis and prognosis of retinal dysfunction in AR. The goal was to identify frequently targeted retinal autoantigens within the 60-70-kDa molecular weight range. Methods. Human retinal proteins were separated by SDS-PAGE and 2D gel electrophoresis (2-DE) and sera from AR patients with and without cancer were used to identify immunoreactive proteins by Western blotting. Proteins were identified following separation by electrophoresis, Coomassie staining using in-gel trypsin digestion and mass spectrometric analysis. Circulating serum hsp60 and anti-hsp60 antibody levels were determined by quantitative ELISA. Results: Retrospective evaluation of 819 patients with anti-retinal AAbs showed that 29% patients had AAbs targeted proteins between 60-70-kDa. Shotgun mass spectrometry of human retinal proteins present in 1D-gel found 66 species within this range. To identify the immunoreactive proteins, we performed Western blots of 2-DE gels and showed a group of heat shock proteins (hsps), including hsp60 and CRMP proteins that were frequently recognized by AR patient AAbs, irrespective of cancer status. These results were validated by immunostaining of purified hsp60 and CRMP2 proteins. ELISA results revealed that patients with AR and CAR had significantly increased levels of serum anti-hsp60 antibodies compared to control healthy subjects (p <0.0001). However, circulating hsp60 protein was not significantly elevated in sera of either patient group. Conclusions: Different anti-retinal antibodies frequently co-exist in a single patient, creating antibody-arrays related to the syndrome. Hsps and CRMP-2 are newly identified autoantigens in AR. A frequent co-association of anti-hsp antibodies with other anti-retinal AAbs may augment pathogenic processes, leading to retinal degeneration.

AB - Background: Autoimmune retinopathy (AR) and Cancer-Associated Retinopathy (CAR) are associated with a diverse repertoire of anti-retinal autoantibodies (AAbs) but not all antigenic targets have been characterized. Identification of new AAbs may help with clinical diagnosis and prognosis of retinal dysfunction in AR. The goal was to identify frequently targeted retinal autoantigens within the 60-70-kDa molecular weight range. Methods. Human retinal proteins were separated by SDS-PAGE and 2D gel electrophoresis (2-DE) and sera from AR patients with and without cancer were used to identify immunoreactive proteins by Western blotting. Proteins were identified following separation by electrophoresis, Coomassie staining using in-gel trypsin digestion and mass spectrometric analysis. Circulating serum hsp60 and anti-hsp60 antibody levels were determined by quantitative ELISA. Results: Retrospective evaluation of 819 patients with anti-retinal AAbs showed that 29% patients had AAbs targeted proteins between 60-70-kDa. Shotgun mass spectrometry of human retinal proteins present in 1D-gel found 66 species within this range. To identify the immunoreactive proteins, we performed Western blots of 2-DE gels and showed a group of heat shock proteins (hsps), including hsp60 and CRMP proteins that were frequently recognized by AR patient AAbs, irrespective of cancer status. These results were validated by immunostaining of purified hsp60 and CRMP2 proteins. ELISA results revealed that patients with AR and CAR had significantly increased levels of serum anti-hsp60 antibodies compared to control healthy subjects (p <0.0001). However, circulating hsp60 protein was not significantly elevated in sera of either patient group. Conclusions: Different anti-retinal antibodies frequently co-exist in a single patient, creating antibody-arrays related to the syndrome. Hsps and CRMP-2 are newly identified autoantigens in AR. A frequent co-association of anti-hsp antibodies with other anti-retinal AAbs may augment pathogenic processes, leading to retinal degeneration.

KW - Autoantibody

KW - Autoantigen

KW - Autoimmune retinopathy

KW - CAR

KW - CRMP-2

KW - Heat shock proteins

KW - Retina

UR - http://www.scopus.com/inward/record.url?scp=84884520559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884520559&partnerID=8YFLogxK

U2 - 10.1186/1471-2415-13-48

DO - 10.1186/1471-2415-13-48

M3 - Article

C2 - 24066722

AN - SCOPUS:84884520559

VL - 13

JO - BMC Ophthalmology

JF - BMC Ophthalmology

SN - 1471-2415

IS - 1

M1 - 48

ER -